The treatment of locally advanced head and neck... (1984 study) Skip to main content
RCT International journal of radiation oncology, biology, physics 1984

The treatment of locally advanced head and neck cancer with misonidazole, hyperbaric oxygen and irradiation: an interim report.

Sealy R, Cridland S, International journal of radiation oncology, biology, physics, 1984

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

The researchers treated patients who had advanced mouth cancer that could not be removed by surgery with a drug called misonidazole plus radiation given inside a hyperbaric oxygen chamber, then began a larger trial to compare this approach with standard radiation in air.

What They Found

In an interim report of a pilot study followed by an ongoing randomized trial, 31 patients with advanced inoperable squamous carcinoma of the mouth received misonidazole with six 6.0 Gy radiation doses in hyperbaric oxygen at 3 ATA, and 48% were free of disease at one year and 26% at two years. The ongoing trial compares this regimen with 63.0 Gy in 30 fractions over 38 days in air. So far 114 patients have been entered, and 91 could be analyzed at six months or more. The preliminary results at 6 and 12 months favor the combination of sensitizers, and the authors report no added toxicity. The abstract gives no statistical test for this comparison.

What This Means for Canadian Patients

This report covers advanced mouth cancer that could not be treated with surgery. The abstract describes the combination of misonidazole, radiation and hyperbaric oxygen at 3 ATA as being tested and gives early results only. It does not report final results, so it cannot show whether this treatment works better than standard radiation. Patients should discuss any treatment options with their cancer care team.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

This is an interim report: the pilot study had no comparison group, the randomized trial results are preliminary and given without numbers or a statistical test, and only 91 of the 114 patients could be analyzed at six months or more.

This plain-language summary was generated with AI assistance from the study's abstract; it has not been individually reviewed by a clinician. Always consult the source study and a qualified healthcare professional. See our editorial policy.

Was this summary helpful?

Study Details

Study Type RCT
Category Radiation Injury
Source Pubmed
PubMed ID 6384161
Year Published 1984
Journal International journal of radiation oncology, biology, physics
MeSH Terms Adult; Aged; Carcinoma, Squamous Cell; Clinical Trials as Topic; Combined Modality Therapy; Head and Neck Neoplasms; Humans; Hyperbaric Oxygenation; Middle Aged; Misonidazole; Nitroimidazoles; Pilot Projects; Prospective Studies; Radiation-Sensitizing Agents; Random Allocation

Cite This Study

Share

This study relates to Delayed Radiation Injury. Read the full clinical overview, the evidence base, and Canadian treatment access for this condition.

Find a Canadian Clinic Treating Radiation Injury

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last updated: April 1, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology